Loading...
Loading...
Among the 7 tracked institutional investors we monitor, AKBA (AKEBIA THREAPEUTICS INC) is held with a combined value of $78.03M across 53,603,286 shares. The largest holder is BlackRock, Inc. with a position worth $25.98M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds increased their holdings. 4 funds reduced their position.
Total Institutional Value
$78.03M
Total Shares Held
53,603,286
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $25.98M | 0.00% | -3.2% |
| 2 | VANGUARD GROUP INC | $25.79M | 0.00% | New |
| 3 | STATE STREET CORP | $16.14M | 0.00% | -15.1% |
| 4 | MILLENNIUM MANAGEMENT LLC | $3.31M | 0.00% | +44.2% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $2.55M | 0.00% | -49.0% |
| 6 | CITADEL ADVISORS LLC | $2.40M | 0.00% | -65.6% |
| 7 | FMR LLC | $1.86M | 0.00% | +18.6% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of AKBA with a position worth $25.98M, representing 0.00% of their portfolio. In total, 7 institutional investors hold AKBA with a combined value of $78.03M.
In the most recent quarter, 1 fund opened a new position in AKBA. Additionally, 2 increased their holdings and 4 reduced their positions.
Institutional investors hold $78.03M worth of AKBA stock across 7 positions. The largest institutional holder is BlackRock, Inc. with $25.98M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For AKBA, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their AKBA positions.